Adamsbrown Wealth Consultants Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck Pharmaceutical ETF
PPH
|
+$6.84M |
| 2 |
First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF
LMBS
|
+$4.75M |
| 3 |
Capital Group Core Plus Income ETF
CGCP
|
+$2.34M |
| 4 |
First Trust Institutional Preferred Securities and Income ETF
FPEI
|
+$1.96M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$1.16M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan International Bond Opportunities ETF
JPIB
|
+$11.9M |
| 2 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$3.63M |
| 3 |
Apple
AAPL
|
+$362K |
| 4 |
Invesco QQQ Trust
QQQ
|
+$329K |
| 5 |
NVO
Novo Nordisk
NVO
|
+$228K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.38% |
| 2 | Financials | 3.78% |
| 3 | Energy | 1.57% |
| 4 | Consumer Staples | 1.39% |
| 5 | Consumer Discretionary | 1.14% |
Similar funds
Adamsbrown Wealth Consultants's Q4 2024 Portfolio in Review
As of Q4 2024, Adamsbrown Wealth Consultants held 101 positions worth $293M, up 1.8% from $288M the previous quarter. Its ten largest holdings account for 71% of the portfolio.
Adamsbrown Wealth Consultants deployed $9M of net new capital in Q4 2024, opening 8 new positions and adding to 61 existing holdings. Its largest new stake was First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF: 97,257 shares worth $4.73M.
By sector, the portfolio is most concentrated in Technology at 4.4% of assets, down from 4.4% a quarter earlier, followed by Financials and Energy.
On the sell side, the largest reduction was JPMorgan International Bond Opportunities ETF, an estimated $11.9M trimmed.
- Adamsbrown Wealth Consultants's largest Q4 2024 buy was First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF: 97,257 shares worth $4.73M.
- Adamsbrown Wealth Consultants added most to VanEck Pharmaceutical ETF in Q4 2024, an estimated $6.84M increase.
- Adamsbrown Wealth Consultants's biggest Q4 2024 reduction was JPMorgan International Bond Opportunities ETF, cutting an estimated $11.9M.
- Adamsbrown Wealth Consultants fully exited Novo Nordisk in Q4 2024, selling an estimated $228K.
- Adamsbrown Wealth Consultants's ten largest holdings make up 71% of its $293M portfolio in Q4 2024.
- Adamsbrown Wealth Consultants opened 8 new positions and closed 4 in Q4 2024.
- Adamsbrown Wealth Consultants's portfolio value rose 1.8% quarter-over-quarter to $293M.
Based on Adamsbrown Wealth Consultants's 13F filing for Q4 2024, filed 24 Jan 2025.